TradAir’s trading solution continues to that are designed to make it more dynamic for different market participants. In this sense, the Israel-based provider of cloud trading technology solutions today revealed a new white label trading technology, which allows its users to access a wider range of client engagement tools.
TradAir has launched a portfolio of white-label capabilities that taps into the REACT framework while offering additional features for both the trading application and Business Intelligence (BI) solution. The company expects the new product to be ‘rapidly’ deployed by banks and institutional brokers.
TradAir is hoping to capture more business by adapting the new offering across all of its modules, including the recently launched “Sales Dealer” as well as trading screens, Pricing Engine and White Label. All these modules can be configured for a variety of business types, allowing their B2C and B2B clients to offer customized applications and workflows to each of their end users.
A busy year for TradAir
TradAir offers its customers access to FX liquidity sourced from major bank and non-bank liquidity providers, delivered via TradAir’s HTML5 eFX platform. The technology developer positioned itself as an ideal partner for many brokerages as the company deploys its servers in several locations, including London, New York, Singapore, and Tel Aviv. The company has recently in a Series D funding round, led by GF Investments and the family office of Harvey Golub, the former CEO of American Express.
Commenting on the news, Ayal Jedeikin, founder and CEO of TradAir, noted: “TradAir was the first to market with institutional quality HTML5 FX trading solutions. Our clients demand more tools and personalization, and our new front-end is the first of several product enhancements, collaboratively derived to provide for the growing demand we see for personalized experience. I am excited at our plans for 2020 where we will continue to innovate the channels between banks/brokers and their clients”
Be First to Comment